Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP 3 randomized clinical trial
PlexusDx offers oral semaglutide at $289/mo month-to-month, or from $249/mo on the 6-month plan for patients who genuinely cannot tolerate injections
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): Wild, S., Roglic, G., Green, A., Sicree, R., & King, H
While traditionally considered first-line therapy, current American Diabetes Association guidance emphasizes a person-centered approach to initial medication selection based on comorbidities, treatment goals, and patient preferences
GLP-1s are contraindicated in some thyroid cancers